Clozapine is the only available treatment for refractory schizophrenia but its use involves
frequent physical contact with healthcare workers for the purpose of mandatory blood …

There is both uncertainty regarding the safety of clozapine in COVID-19 patients owing to
limited published data and a lack of consensus on continuing clozapine in patients with …

The Dutch Clozapine Collaboration Group is frequently asked for advice about the
management of clozapine-treated patients when infected with or vaccinated against SARS …

Abstract Using Richardson and Davidson's model and the sciences of pharmacokinetics and
clinical pharmacopsychology, this article reviewed the:(1) poor life expectancy associated …

Clozapine is the most effective antipsychotic for treatment resistant schizophrenia but
adverse reactions to clozapine include neutropenia. The current COVID-19 pandemic may …

The global COVID-19 pandemic has disrupted every aspect of the healthcare system. Apart
from the issues surrounding COVID-19 itself, care for existing patients has met many …

With the ongoing coronavirus disease 2019 (COVID-19) pandemic, psychiatrists find
themselves in the clinical situation of being asked by patients, family members and patient …

Background Clozapine is among the most effective antipsychotics used for treatment
resistant schizophrenia. Adverse reactions to clozapine include neutropenia. In March 2020 …

We would like to describe a case of clozapine intoxication as a result of COVID-19 infection.
As far as we are aware, an example of this has not yet been described. In patients treated …

Background Monitoring of white cell counts during clozapine treatment leads to cessation of
therapy if levels fall below pre-determined values. Reductions in white cell counts, driven by …